Approaching Genomics and Bioinformatics of everyday life
A new and important genomic analysis company will soon be on the market: GENOMAis.
GENOMAis is a provider of services and products in the post-next-gen sequencing (NGS) market that aims to bring genomics and bioinformatics closer to the lives of Brazilian users (be they patients, physicians, professionals / health agents or the general public) Who want to get accurate information about their DNA, as well as being a genomic services provider and a developer of direct genomic tests (the so-called genomic self-tests).
- GENOMIC MEDICINE (diagnosis and therapy),
- PERSONAL GENOMICS (direct consumer testing),
- GENOMIC FORENSICS
- PREVENTIVE (expert support to public authorities and security and justice) and other possible applications (food safety, precision farming, etc.)
Being a “Frontier Company of Support to (Bio) Personalized Medicine in Ceará”, GENOMAis offers services and products of high quality in analyzes of the human genome (besides animal, environmental and alimentary) through technologies of sequencing of new generation (NGS ) Of DNA / RNA.
Providing easy (fast and simple) access to genomic features via well-generated, analyzed and interpreted DNA / RNA data is the innovative contribution of this company that promises to bring Personalized Medicine within reach of all social classes.
After all, the demands for genomic-based clinical information are the most convergent current challenge in the world, and only through the regular domain of Information Technology (IT) and NGS will we achieve this new level of targeted, fast / precocious, precise diagnosis , Reliable and indispensable that set the world standard of the call to Health Care of Next Generation (or NextGen Healthcare).
GENOMAis enters this scenario to contribute to the education and implementation of a new (and urgently needed) genomic (medicine / information) culture in Ceará and Brazil, instituting Continuous Action Plans and Agreements to ensure the local execution of these genomic examinations in different Clinical support in its adoption (from the requisition until the interpretation of the genomic tests) and providing all assistance in the proper use of the laboratory results in the medical decision making.
In addition, GENOMAis is active in the areas of Clinical, Forensic and Personal Genomics, introducing its first genomic self-tests (or direct consumer tests) as soon as they are approved by ANVISA.